184 related articles for article (PubMed ID: 30293996)
1. A minority-group of renal cell cancer patients with high infiltration of CD20+B-cells is associated with poor prognosis.
Sjöberg E; Frödin M; Lövrot J; Mezheyeuski A; Johansson M; Harmenberg U; Egevad L; Sandström P; Östman A
Br J Cancer; 2018 Oct; 119(7):840-846. PubMed ID: 30293996
[TBL] [Abstract][Full Text] [Related]
2. Nuclear and stromal expression of Manic fringe in renal cell carcinoma.
Cheng WK; Kaur G; Sjöberg E; Frödin M; Egevad L; Harmenberg U; Li JL; Oon CE
Exp Mol Pathol; 2021 Oct; 122():104667. PubMed ID: 34371013
[TBL] [Abstract][Full Text] [Related]
3. B-cell transcription factor expression and immunoglobulin gene rearrangement frequency in acute myeloid leukemia with t(8;21)(q22;q22).
Johnson RC; Ma L; Cherry AM; Arber DA; George TI
Am J Clin Pathol; 2013 Sep; 140(3):355-62. PubMed ID: 23955454
[TBL] [Abstract][Full Text] [Related]
4. CD19 and CD20 targeted vectors induce minimal activation of resting B lymphocytes.
Kneissl S; Zhou Q; Schwenkert M; Cosset FL; Verhoeyen E; Buchholz CJ
PLoS One; 2013; 8(11):e79047. PubMed ID: 24244415
[TBL] [Abstract][Full Text] [Related]
5. A 17-Gene Signature Predicted Prognosis in Renal Cell Carcinoma.
Li F; Hu W; Zhang W; Li G; Guo Y
Dis Markers; 2020; 2020():8352809. PubMed ID: 32184905
[TBL] [Abstract][Full Text] [Related]
6. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
[TBL] [Abstract][Full Text] [Related]
7. JAK3 is a potential biomarker and associated with immune infiltration in kidney renal clear cell carcinoma.
Liang F; Liang H; Li Z; Huang P
Int Immunopharmacol; 2020 Sep; 86():106706. PubMed ID: 32570038
[TBL] [Abstract][Full Text] [Related]
8. The combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome.
Arias-Pulido H; Cimino-Mathews A; Chaher N; Qualls C; Joste N; Colpaert C; Marotti JD; Foisey M; Prossnitz ER; Emens LA; Fiering S
Breast Cancer Res Treat; 2018 Sep; 171(2):273-282. PubMed ID: 29858752
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer.
Lundgren S; Berntsson J; Nodin B; Micke P; Jirström K
J Ovarian Res; 2016 Apr; 9():21. PubMed ID: 27048364
[TBL] [Abstract][Full Text] [Related]
10. An immunosuppressive macrophage profile attenuates the prognostic impact of CD20-positive B cells in human soft tissue sarcoma.
Tsagozis P; Augsten M; Zhang Y; Li T; Hesla A; Bergh J; Haglund F; Tobin NP; Ehnman M
Cancer Immunol Immunother; 2019 Jun; 68(6):927-936. PubMed ID: 30879106
[TBL] [Abstract][Full Text] [Related]
11. Circulating and tissue IMP3 levels are correlated with poor survival in renal cell carcinoma.
Tschirdewahn S; Panic A; Püllen L; Harke NN; Hadaschik B; Riesz P; Horváth A; Szalontai J; Nyirády P; Baba HA; Reis H; Szarvas T
Int J Cancer; 2019 Jul; 145(2):531-539. PubMed ID: 30650187
[TBL] [Abstract][Full Text] [Related]
12. CD20+ B-cell infiltration is related to the time after transplant and poor prognosis of acute cellular rejection in renal transplant.
Jiqiu W; Jinsong C; Dongrui C; Mingchao Z; Shuming J; Zhi-Hong L
Exp Clin Transplant; 2013 Oct; 11(5):412-7. PubMed ID: 23428174
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of promoter CpG island methylation of obesity-related genes in patients with nonmetastatic renal cell carcinoma.
Mendoza-Pérez J; Gu J; Herrera LA; Tannir NM; Zhang S; Matin S; Karam JA; Wood CG; Wu X
Cancer; 2017 Sep; 123(18):3617-3627. PubMed ID: 28543182
[TBL] [Abstract][Full Text] [Related]
14. Galectin 9 and PINCH, novel immunotherapy targets of renal cell carcinoma: a rationale to find potential tumour antigens and the resulting cytotoxic T lymphocytes induced by the derived peptides.
Kawashima H; Obayashi A; Kawamura M; Masaki S; Tamada S; Iguchi T; Uchida J; Kuratsukuri K; Tanaka T; Nakatani T
BJU Int; 2014 Feb; 113(2):320-32. PubMed ID: 24895689
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome.
Garg K; Maurer M; Griss J; Brüggen MC; Wolf IH; Wagner C; Willi N; Mertz KD; Wagner SN
Hum Pathol; 2016 Aug; 54():157-64. PubMed ID: 27107457
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer.
Berntsson J; Nodin B; Eberhard J; Micke P; Jirström K
Int J Cancer; 2016 Sep; 139(5):1129-39. PubMed ID: 27074317
[TBL] [Abstract][Full Text] [Related]
17. CD20 as a gatekeeper of the resting state of human B cells.
Kläsener K; Jellusova J; Andrieux G; Salzer U; Böhler C; Steiner SN; Albinus JB; Cavallari M; Süß B; Voll RE; Boerries M; Wollscheid B; Reth M
Proc Natl Acad Sci U S A; 2021 Feb; 118(7):. PubMed ID: 33563755
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 10-expressing B cells inhibit tumor-infiltrating T cell function and correlate with T cell Tim-3 expression in renal cell carcinoma.
Cai C; Zhang J; Li M; Wu ZJ; Song KH; Zhan TW; Wang LH; Sun YH
Tumour Biol; 2016 Jun; 37(6):8209-18. PubMed ID: 26715281
[TBL] [Abstract][Full Text] [Related]
19. Clonotypic CD20+ and CD19+ B cells in peripheral blood of patients with multiple myeloma post high-dose therapy and peripheral blood stem cell transplantation.
Rottenburger C; Kiel K; Bösing T; Cremer FW; Moldenhauer G; Ho AD; Goldschmidt H; Moos M
Br J Haematol; 1999 Aug; 106(2):545-52. PubMed ID: 10460621
[TBL] [Abstract][Full Text] [Related]
20. Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma.
Garnelo M; Tan A; Her Z; Yeong J; Lim CJ; Chen J; Lim KH; Weber A; Chow P; Chung A; Ooi LL; Toh HC; Heikenwalder M; Ng IO; Nardin A; Chen Q; Abastado JP; Chew V
Gut; 2017 Feb; 66(2):342-351. PubMed ID: 26669617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
